Skip to main content
. 2017 May 31;22(6):913. doi: 10.3390/molecules22060913

Figure 5.

Figure 5

Figure 5

Compounds 8–12 inhibited tube formation induced by VEGF. Reprehensive photographs of tube formation (a) solvent control; (b) VEGFR 10 ng/mL and 70 μM of suramin; (c) VEGF 10 ng/mL and 0.50 μM of sunitinib; (d) VEGF 10 ng/mL and 0.25 μM of sunitinib; (e) VEGF 10 ng/mL and 0.10 μM of sunitinib; (f) VEGF 10 ng/mL and 0.50 μM of 8; (g) VEGF 10 ng/mL and 0.25 μM of 8; (h) VEGF 10 ng/mL and 0.10 μM of 8; (i) VEGF 10 ng/mL and 0.50 μM of 9; (j) VEGF 10 ng/mL and 0.25 μM of 9; (k) VEGF 10 ng/mL and 0.10 μM of 9; (l) VEGF 10 ng/mL and 0.50 μM of 10; (m) VEGF 10 ng/mL and 0.25 μM of 10; (n) VEGF 10 ng/mL and 0.10 μM of 10; (o) VEGF 10 ng/mL and 0.50 μM of 11; (p) VEGF 10 ng/mL and 0.25 μM of 11; (q) VEGF 10 ng/mL and 0.10 μM of 11; (r) VEGF 10 ng/mL and 0.50 μM of 12; (s) VEGF 10 ng/mL and 0.25 μM of 12; (t)VEGF 10 ng/mL and 0.10 μM of 12. Scale bar = 100 μm.